VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q44280577  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235744.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q44280577‏
024 ‎‡a  0000-0002-3745-3885‏ ‎‡2  orcid‏
024 ‎‡a  15033070900‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q44280577‏
100 0 ‎‡a  جون جي جونز‏ ‎‡9  ar‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  John G. Jones‏ ‎‡9  es‏ ‎‡9  sl‏ ‎‡9  ast‏
400 0 ‎‡a  জন জি জোন্স‏ ‎‡c  গবেষক‏ ‎‡9  bn‏
400 0 ‎‡a  John G. Jones‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  John G. Jones‏ ‎‡c  onderzoeker‏ ‎‡9  nl‏
670 ‎‡a  Author's ²H enrichment distribution of hepatic glycogen from ²H₂O reveals the contribution of dietary fructose to glycogen synthesis‏
670 ‎‡a  Author's 2H2O incorporation into hepatic acetyl-CoA and de novo lipogenesis as measured by Krebs cycle-mediated 2H-enrichment of glutamate and glutamine.‏
670 ‎‡a  Author's A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice‏
670 ‎‡a  Author's A Mitochondrial Approach to Cardiovascular Risk and Disease‏
670 ‎‡a  Author's Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen‏
670 ‎‡a  Author's Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance‏
670 ‎‡a  Author's Analysis of glucose metabolism in farmed European sea bass (Dicentrarchus labrax L.) using deuterated water.‏
670 ‎‡a  Author's Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis‏
670 ‎‡a  Author's Chitosan-Mediated shRNA Knockdown of Cytosolic Alanine Aminotransferase Improves Hepatic Carbohydrate Metabolism‏
670 ‎‡a  Author's Contribution of dietary starch to hepatic and systemic carbohydrate fluxes in European seabass (Dicentrarchus labrax L.).‏
670 ‎‡a  Author's Contribution of proteolytic and metabolic sources to hepatic glutamine by (2)H NMR analysis of urinary phenylacetylglutamine (2)H-enrichment from (2)H(2)O.‏
670 ‎‡a  Author's Contribution of various substrates to total citric acid cycle flux and anaplerosis as determined by 13C isotopomer analysis and O2 consumption in the heart‏
670 ‎‡a  Author's Demonstration of glucose-6-phosphate hydrogen 5 enrichment from deuterated water by transaldolase-mediated exchange alone‏
670 ‎‡a  Author's Determination of muscle protein synthesis rates in fish using (2)H2O and (2)H NMR analysis of alanine‏
670 ‎‡a  Author's Determining contributions of exogenous glucose and fructose to de novo fatty acid and glycerol synthesis in liver and adipose tissue‏
670 ‎‡a  Author's Direct analysis of [6,6-2H2]glucose and [U-13C6]glucose dry blood spot enrichments by LC–MS/MS‏
670 ‎‡a  Author's Disposition of a Glucose Load into Hepatic Glycogen by Direct and Indirect Pathways in Juvenile Seabass and Seabream.‏
670 ‎‡a  Author's Disposition of [U-2H7]glucose into hepatic glycogen in rat and in seabass‏
670 ‎‡a  Author's Effect of Global ATGL Knockout on Murine Fasting Glucose Kinetics‏
670 ‎‡a  Author's Effects of alanine aminotransferase inhibition on the intermediary metabolism in Sparus aurata through dietary amino-oxyacetate supplementation‏
670 ‎‡a  Author's Effects of an oral insulin nanoparticle administration on hepatic glucose metabolism assessed by ¹³C and ²H isotopomer analysis‏
670 ‎‡a  Author's Effects of dietary carbohydrate on hepatic de novo lipogenesis in European seabass (Dicentrarchus labrax L.).‏
670 ‎‡a  Author's Effects of different oxidative insults on intermediary metabolism in isolated perfused rat hearts‏
670 ‎‡a  Author's Effects of food-deprivation and refeeding on the regulation and sources of blood glucose appearance in European seabass‏
670 ‎‡a  Author's Effects of food-deprivation and refeeding on the regulation and sources of blood glucose appearance in European seabass (Dicentrarchus labrax L.).‏
670 ‎‡a  Author's Elimination of glucose contamination from adipocyte glycogen extracts‏
670 ‎‡a  Author's Estimating pentose phosphate pathway activity from the analysis of hepatic glycogen 13 C-isotopomers derived from [U-13 C]fructose and [U-13 C]glucose‏
670 ‎‡a  Author's Evidence of extensive plasma glucose recycling following a glucose load in seabass‏
670 ‎‡a  Author's Expressional regulation of key hepatic enzymes of intermediary metabolism in European seabass‏
670 ‎‡a  Author's Expressional regulation of key hepatic enzymes of intermediary metabolism in European seabass (Dicentrarchus labrax) during food deprivation and refeeding.‏
670 ‎‡a  Author's Glycated hemoglobin and associated risk factors in older adults.‏
670 ‎‡a  Author's Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease.‏
670 ‎‡a  Author's Hepatic UDP-glucose 13C isotopomers from [U-13C]glucose: a simple analysis by 13C NMR of urinary menthol glucuronide.‏
670 ‎‡a  Author's Impact of dietary starch on extrahepatic tissue lipid metabolism in farmed European (Dicentrarchus labrax) and Asian seabass (Lates calcarifer)‏
670 ‎‡a  Author's Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes‏
670 ‎‡a  Author's Improving Metabolic Control Through Functional Foods.‏
670 ‎‡a  Author's Induction of lipogenesis in white fat during cold exposure in mice: link to lean phenotype.‏
670 ‎‡a  Author's Intestinal Microbial and Metabolic Profiling of Mice Fed with High-Glucose and High-Fructose Diets‏
670 ‎‡a  Author's Ketone bodies effectively compete with glucose for neuronal acetyl-CoA generation in rat hippocampal slices‏
670 ‎‡a  Author's Measurement of gluconeogenesis and pyruvate recycling in the rat liver: a simple analysis of glucose and glutamate isotopomers during metabolism of [1,2,3-(13)C3]propionate.‏
670 ‎‡a  Author's Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans.‏
670 ‎‡a  Author's Metabolic characterisation of plasma in juveniles with glycogen storage disease type 1a‏
670 ‎‡a  Author's Metabolic characterisation of plasma in juveniles with glycogen storage disease type 1a (GSD1a) by high-resolution1H NMR spectroscopy‏
670 ‎‡a  Author's Metabolic incorporation of H2 18 O into specific glucose-6-phosphate oxygens by red-blood-cell lysates as observed by 13 C isotope-shifted NMR signals‏
670 ‎‡a  Author's Metabolic plasticity for subcutaneous fat accumulation in a long-distance migratory bird traced by 2H2O.‏
670 ‎‡a  Author's Noninvasive evaluation of liver metabolism by 2H and 13C NMR isotopomer analysis of human urine‏
670 ‎‡a  Author's Noninvasive measurement of murine hepatic acetyl-CoA ¹³C-enrichment following overnight feeding with ¹³C-enriched fructose and glucose‏
670 ‎‡a  Author's Orientation-conserved transfer of symmetric Krebs cycle intermediates in mammalian tissue‏
670 ‎‡a  Author's p-Aminobenzoic acid as an alternative chemical biopsy agent for human hepatic UDP-glucose‏
670 ‎‡a  Author's Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes.‏
670 ‎‡a  Author's Quantification of hepatic transaldolase exchange activity and its effects on tracer measurements of indirect pathway flux in humans‏
670 ‎‡a  Author's Quantifying endogenous glucose production and contributing source fluxes from a single 2H NMR spectrum.‏
670 ‎‡a  Author's Quantifying hepatic glycogen synthesis by direct and indirect pathways in rats under normal ad libitum feeding conditions‏
670 ‎‡a  Author's Quantitation of erythrocyte pentose pathway flux with [2-13C]glucose and 1H NMR analysis of the lactate methyl signal‏
670 ‎‡a  Author's Reduced α-MSH Underlies Hypothalamic ER-Stress-Induced Hepatic Gluconeogenesis.‏
670 ‎‡a  Author's Resolving the sources of plasma glucose excursions following a glucose tolerance test in the rat with deuterated water and [U-13C]glucose‏
670 ‎‡a  Author's Restoration of direct pathway glycogen synthesis flux in the STZ-diabetes rat model by insulin administration.‏
670 ‎‡a  Author's Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition‏
670 ‎‡a  Author's Sources of acetyl-CoA entering the tricarboxylic acid cycle as determined by analysis of succinate 13C isotopomers‏
670 ‎‡a  Author's Sources of endogenous glucose production in the Goto-Kakizaki diabetic rat.‏
670 ‎‡a  Author's Sources of hepatic glycogen synthesis during an oral glucose tolerance test: Effect of transaldolase exchange on flux estimates‏
670 ‎‡a  Author's Sources of hepatic glycogen synthesis following a milk-containing breakfast meal in healthy subjects.‏
670 ‎‡a  Author's Sources of hepatic glycogen synthesis in mice fed with glucose or fructose as the sole dietary carbohydrate‏
670 ‎‡a  Author's The Administration of Chitosan-Tripolyphosphate-DNA Nanoparticles to Express Exogenous SREBP1a Enhances Conversion of Dietary Carbohydrates into Lipids in the Liver of Sparus aurata‏
670 ‎‡a  Author's The Potential of Metabolomics in the Diagnosis of Thyroid Cancer‏
670 ‎‡a  Author's Toxicological assessment of orally delivered nanoparticulate insulin‏
670 ‎‡a  Author's Toxicological in vivo studies of an oral insulin nanosystem‏
670 ‎‡a  Author's Transaldolase exchange and its effects on measurements of gluconeogenesis in humans‏
670 ‎‡a  Author's Transfer of glucose hydrogens via acetyl-CoA, malonyl-CoA, and NADPH to fatty acids during de novo lipogenesis‏
670 ‎‡a  Author's Tricarboxylic acid cycle inhibition by Li+ in the human neuroblastoma SH-SY5Y cell line: a 13C NMR isotopomer analysis‏
670 ‎‡a  Author's Understanding how birds rebuild fat stores during migration: insights from an experimental study‏
670 ‎‡a  Author's Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes‏
670 ‎‡a  Author's Ursodeoxycholic acid treatment of hepatic steatosis: a‏
670 ‎‡a  Author's Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study‏
909 ‎‡a  (scopus) 15033070900‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000237453885‏ ‎‡9  1‏
919 ‎‡a  expressionalregulationofkeyhepaticenzymesofintermediarymetabolismineuropeanseabass‏ ‎‡A  Expressional regulation of key hepatic enzymes of intermediary metabolism in European seabass‏ ‎‡9  1‏
919 ‎‡a  evidenceofextensiveplasmaglucoserecyclingfollowingaglucoseloadinseabass‏ ‎‡A  Evidence of extensive plasma glucose recycling following a glucose load in seabass‏ ‎‡9  1‏
919 ‎‡a  estimatingpentosephosphatepathwayactivityfromtheanalysisofhepaticglycogen13100isotopomersderivedfromfructoseandglucose‏ ‎‡A  Estimating pentose phosphate pathway activity from the analysis of hepatic glycogen 13 C-isotopomers derived from [U-13 C]fructose and [U-13 C]glucose‏ ‎‡9  1‏
919 ‎‡a  eliminationofglucosecontaminationfromadipocyteglycogenextracts‏ ‎‡A  Elimination of glucose contamination from adipocyte glycogen extracts‏ ‎‡9  1‏
919 ‎‡a  effectsoffooddeprivationandrefeedingontheregulationandsourcesofbloodglucoseappearanceineuropeanseabassdicentrarchuslabrax50‏ ‎‡A  Effects of food-deprivation and refeeding on the regulation and sources of blood glucose appearance in European seabass (Dicentrarchus labrax L.).‏ ‎‡9  1‏
919 ‎‡a  effectsoffooddeprivationandrefeedingontheregulationandsourcesofbloodglucoseappearanceineuropeanseabass‏ ‎‡A  Effects of food-deprivation and refeeding on the regulation and sources of blood glucose appearance in European seabass‏ ‎‡9  1‏
919 ‎‡a  effectsofdifferentoxidativeinsultsonintermediarymetabolisminisolatedperfusedrathearts‏ ‎‡A  Effects of different oxidative insults on intermediary metabolism in isolated perfused rat hearts‏ ‎‡9  1‏
919 ‎‡a  effectsofdietarycarbohydrateonhepaticdenovolipogenesisineuropeanseabassdicentrarchuslabrax50‏ ‎‡A  Effects of dietary carbohydrate on hepatic de novo lipogenesis in European seabass (Dicentrarchus labrax L.).‏ ‎‡9  1‏
919 ‎‡a  effectsofanoralinsulinnanoparticleadministrationonhepaticglucosemetabolismassessedby13cand2hisotopomeranalysis‏ ‎‡A  Effects of an oral insulin nanoparticle administration on hepatic glucose metabolism assessed by ¹³C and ²H isotopomer analysis‏ ‎‡9  1‏
919 ‎‡a  effectsofalanineaminotransferaseinhibitionontheintermediarymetabolisminsparusauratathroughdietaryaminooxyacetatesupplementation‏ ‎‡A  Effects of alanine aminotransferase inhibition on the intermediary metabolism in Sparus aurata through dietary amino-oxyacetate supplementation‏ ‎‡9  1‏
919 ‎‡a  effectofglobalatglknockoutonmurinefastingglucosekinetics‏ ‎‡A  Effect of Global ATGL Knockout on Murine Fasting Glucose Kinetics‏ ‎‡9  1‏
919 ‎‡a  dispositionofglucoseintohepaticglycogeninratandinseabass‏ ‎‡A  Disposition of [U-2H7]glucose into hepatic glycogen in rat and in seabass‏ ‎‡9  1‏
919 ‎‡a  dispositionofaglucoseloadintohepaticglycogenbydirectandindirectpathwaysinjuvenileseabassandseabream‏ ‎‡A  Disposition of a Glucose Load into Hepatic Glycogen by Direct and Indirect Pathways in Juvenile Seabass and Seabream.‏ ‎‡9  1‏
919 ‎‡a  directanalysisofglucoseandglucosedrybloodspotenrichmentsbylcmsms‏ ‎‡A  Direct analysis of [6,6-2H2]glucose and [U-13C6]glucose dry blood spot enrichments by LC–MS/MS‏ ‎‡9  1‏
919 ‎‡a  determiningcontributionsofexogenousglucoseandfructosetodenovofattyacidandglycerolsynthesisinliverandadiposetissue‏ ‎‡A  Determining contributions of exogenous glucose and fructose to de novo fatty acid and glycerol synthesis in liver and adipose tissue‏ ‎‡9  1‏
919 ‎‡a  determinationofmuscleproteinsynthesisratesinfishusing2h2oand2hnmranalysisofalanine‏ ‎‡A  Determination of muscle protein synthesis rates in fish using (2)H2O and (2)H NMR analysis of alanine‏ ‎‡9  1‏
919 ‎‡a  demonstrationofglucose6phosphatehydrogen5enrichmentfromdeuteratedwaterbytransaldolasemediatedexchangealone‏ ‎‡A  Demonstration of glucose-6-phosphate hydrogen 5 enrichment from deuterated water by transaldolase-mediated exchange alone‏ ‎‡9  1‏
919 ‎‡a  contributionofvarioussubstratestototalcitricacidcyclefluxandanaplerosisasdeterminedby13cisotopomeranalysisando2consumptionintheheart‏ ‎‡A  Contribution of various substrates to total citric acid cycle flux and anaplerosis as determined by 13C isotopomer analysis and O2 consumption in the heart‏ ‎‡9  1‏
919 ‎‡a  contributionofproteolyticandmetabolicsourcestohepaticglutamineby2hnmranalysisofurinaryphenylacetylglutamine2henrichmentfrom2h2o‏ ‎‡A  Contribution of proteolytic and metabolic sources to hepatic glutamine by (2)H NMR analysis of urinary phenylacetylglutamine (2)H-enrichment from (2)H(2)O.‏ ‎‡9  1‏
919 ‎‡a  contributionofdietarystarchtohepaticandsystemiccarbohydratefluxesineuropeanseabassdicentrarchuslabrax50‏ ‎‡A  Contribution of dietary starch to hepatic and systemic carbohydrate fluxes in European seabass (Dicentrarchus labrax L.).‏ ‎‡9  1‏
919 ‎‡a  chitosanmediatedshrnaknockdownofcytosolicalanineaminotransferaseimproveshepaticcarbohydratemetabolism‏ ‎‡A  Chitosan-Mediated shRNA Knockdown of Cytosolic Alanine Aminotransferase Improves Hepatic Carbohydrate Metabolism‏ ‎‡9  1‏
919 ‎‡a  berberineprotectsagainsthighfatdietinduceddysfunctioninmusclemitochondriabyinducingsirt1dependentmitochondrialbiogenesis‏ ‎‡A  Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis‏ ‎‡9  1‏
919 ‎‡a  analysisofglucosemetabolisminfarmedeuropeanseabassdicentrarchuslabrax50usingdeuteratedwater‏ ‎‡A  Analysis of glucose metabolism in farmed European sea bass (Dicentrarchus labrax L.) using deuterated water.‏ ‎‡9  1‏
919 ‎‡a  acutedietaryfatintakeinitiatesalterationsinenergymetabolismandinsulinresistance‏ ‎‡A  Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance‏ ‎‡9  1‏
919 ‎‡a  activationofdirectandindirectpathwaysofglycogensynthesisbyhepaticoverexpressionofproteintargetingtoglycogen‏ ‎‡A  Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen‏ ‎‡9  1‏
919 ‎‡a  mitochondrialapproachtocardiovascularriskanddisease‏ ‎‡A  A Mitochondrial Approach to Cardiovascular Risk and Disease‏ ‎‡9  1‏
919 ‎‡a  highfatdietsuppressesdenovolipogenesisanddesaturationbutnotelongationandtriglyceridesynthesisinmice‏ ‎‡A  A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice‏ ‎‡9  1‏
919 ‎‡a  2h2oincorporationintohepaticacetylcoaanddenovolipogenesisasmeasuredbykrebscyclemediated2henrichmentofglutamateandglutamine‏ ‎‡A  2H2O incorporation into hepatic acetyl-CoA and de novo lipogenesis as measured by Krebs cycle-mediated 2H-enrichment of glutamate and glutamine.‏ ‎‡9  1‏
919 ‎‡a  2henrichmentdistributionofhepaticglycogenfrom2h2orevealsthecontributionofdietaryfructosetoglycogensynthesis‏ ‎‡A  ²H enrichment distribution of hepatic glycogen from ²H₂O reveals the contribution of dietary fructose to glycogen synthesis‏ ‎‡9  1‏
919 ‎‡a  quantifyingendogenousglucoseproductionandcontributingsourcefluxesfromasingle2hnmrspectrum‏ ‎‡A  Quantifying endogenous glucose production and contributing source fluxes from a single 2H NMR spectrum.‏ ‎‡9  1‏
919 ‎‡a  quantifyinghepaticglycogensynthesisbydirectandindirectpathwaysinratsundernormaladlibitumfeedingconditions‏ ‎‡A  Quantifying hepatic glycogen synthesis by direct and indirect pathways in rats under normal ad libitum feeding conditions‏ ‎‡9  1‏
919 ‎‡a  quantitationoferythrocytepentosepathwayfluxwithglucoseand1hnmranalysisofthelactatemethylsignal‏ ‎‡A  Quantitation of erythrocyte pentose pathway flux with [2-13C]glucose and 1H NMR analysis of the lactate methyl signal‏ ‎‡9  1‏
919 ‎‡a  reducedαmshunderlieshypothalamicerstressinducedhepaticgluconeogenesis‏ ‎‡A  Reduced α-MSH Underlies Hypothalamic ER-Stress-Induced Hepatic Gluconeogenesis.‏ ‎‡9  1‏
919 ‎‡a  resolvingthesourcesofplasmaglucoseexcursionsfollowingaglucosetolerancetestintheratwithdeuteratedwaterandglucose‏ ‎‡A  Resolving the sources of plasma glucose excursions following a glucose tolerance test in the rat with deuterated water and [U-13C]glucose‏ ‎‡9  1‏
919 ‎‡a  restorationofdirectpathwayglycogensynthesisfluxinthestzdiabetesratmodelbyinsulinadministration‏ ‎‡A  Restoration of direct pathway glycogen synthesis flux in the STZ-diabetes rat model by insulin administration.‏ ‎‡9  1‏
919 ‎‡a  rhokinaseampkaxisregulateshepaticlipogenesisduringovernutrition‏ ‎‡A  Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition‏ ‎‡9  1‏
919 ‎‡a  sourcesofacetylcoaenteringthetricarboxylicacidcycleasdeterminedbyanalysisofsuccinate13cisotopomers‏ ‎‡A  Sources of acetyl-CoA entering the tricarboxylic acid cycle as determined by analysis of succinate 13C isotopomers‏ ‎‡9  1‏
919 ‎‡a  sourcesofendogenousglucoseproductioninthegotokakizakidiabeticrat‏ ‎‡A  Sources of endogenous glucose production in the Goto-Kakizaki diabetic rat.‏ ‎‡9  1‏
919 ‎‡a  sourcesofhepaticglycogensynthesisduringanoralglucosetolerancetesteffectoftransaldolaseexchangeonfluxestimates‏ ‎‡A  Sources of hepatic glycogen synthesis during an oral glucose tolerance test: Effect of transaldolase exchange on flux estimates‏ ‎‡9  1‏
919 ‎‡a  sourcesofhepaticglycogensynthesisfollowingamilkcontainingbreakfastmealinhealthysubjects‏ ‎‡A  Sources of hepatic glycogen synthesis following a milk-containing breakfast meal in healthy subjects.‏ ‎‡9  1‏
919 ‎‡a  sourcesofhepaticglycogensynthesisinmicefedwithglucoseorfructoseasthesoledietarycarbohydrate‏ ‎‡A  Sources of hepatic glycogen synthesis in mice fed with glucose or fructose as the sole dietary carbohydrate‏ ‎‡9  1‏
919 ‎‡a  administrationofchitosantripolyphosphatednananoparticlestoexpressexogenoussrebp1aenhancesconversionofdietarycarbohydratesintolipidsintheliverofsparusaurata‏ ‎‡A  The Administration of Chitosan-Tripolyphosphate-DNA Nanoparticles to Express Exogenous SREBP1a Enhances Conversion of Dietary Carbohydrates into Lipids in the Liver of Sparus aurata‏ ‎‡9  1‏
919 ‎‡a  potentialofmetabolomicsinthediagnosisofthyroidcancer‏ ‎‡A  The Potential of Metabolomics in the Diagnosis of Thyroid Cancer‏ ‎‡9  1‏
919 ‎‡a  toxicologicalassessmentoforallydeliverednanoparticulateinsulin‏ ‎‡A  Toxicological assessment of orally delivered nanoparticulate insulin‏ ‎‡9  1‏
919 ‎‡a  toxicologicalinvivostudiesofanoralinsulinnanosystem‏ ‎‡A  Toxicological in vivo studies of an oral insulin nanosystem‏ ‎‡9  1‏
919 ‎‡a  transaldolaseexchangeanditseffectsonmeasurementsofgluconeogenesisinhumans‏ ‎‡A  Transaldolase exchange and its effects on measurements of gluconeogenesis in humans‏ ‎‡9  1‏
919 ‎‡a  transferofglucosehydrogensviaacetylcoamalonylcoaandnadphtofattyacidsduringdenovolipogenesis‏ ‎‡A  Transfer of glucose hydrogens via acetyl-CoA, malonyl-CoA, and NADPH to fatty acids during de novo lipogenesis‏ ‎‡9  1‏
919 ‎‡a  tricarboxylicacidcycleinhibitionbyli+inthehumanneuroblastomashsy5ycelllinea13cnmrisotopomeranalysis‏ ‎‡A  Tricarboxylic acid cycle inhibition by Li+ in the human neuroblastoma SH-SY5Y cell line: a 13C NMR isotopomer analysis‏ ‎‡9  1‏
919 ‎‡a  understandinghowbirdsrebuildfatstoresduringmigrationinsightsfromanexperimentalstudy‏ ‎‡A  Understanding how birds rebuild fat stores during migration: insights from an experimental study‏ ‎‡9  1‏
919 ‎‡a  uptakeandmetaboliceffectsofinsulinmimeticoxovanadiumcompoundsinhumanerythrocytes‏ ‎‡A  Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes‏ ‎‡9  1‏
919 ‎‡a  ursodeoxycholicacidtreatmentofhepaticsteatosisa‏ ‎‡A  Ursodeoxycholic acid treatment of hepatic steatosis: a‏ ‎‡9  1‏
919 ‎‡a  ursodeoxycholicacidtreatmentofhepaticsteatosisa13100nmrmetabolicstudy‏ ‎‡A  Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study‏ ‎‡9  1‏
919 ‎‡a  quantificationofhepatictransaldolaseexchangeactivityanditseffectsontracermeasurementsofindirectpathwayfluxinhumans‏ ‎‡A  Quantification of hepatic transaldolase exchange activity and its effects on tracer measurements of indirect pathway flux in humans‏ ‎‡9  1‏
919 ‎‡a  postprandialandfastinghepaticglucosefluxesinlongstandingtype1diabetes‏ ‎‡A  Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes.‏ ‎‡9  1‏
919 ‎‡a  paminobenzoicacidasanalternativechemicalbiopsyagentforhumanhepaticudpglucose‏ ‎‡A  p-Aminobenzoic acid as an alternative chemical biopsy agent for human hepatic UDP-glucose‏ ‎‡9  1‏
919 ‎‡a  orientationconservedtransferofsymmetrickrebscycleintermediatesinmammaliantissue‏ ‎‡A  Orientation-conserved transfer of symmetric Krebs cycle intermediates in mammalian tissue‏ ‎‡9  1‏
919 ‎‡a  noninvasivemeasurementofmurinehepaticacetylcoa13cenrichmentfollowingovernightfeedingwith13cenrichedfructoseandglucose‏ ‎‡A  Noninvasive measurement of murine hepatic acetyl-CoA ¹³C-enrichment following overnight feeding with ¹³C-enriched fructose and glucose‏ ‎‡9  1‏
919 ‎‡a  noninvasiveevaluationoflivermetabolismby2hand13cnmrisotopomeranalysisofhumanurine‏ ‎‡A  Noninvasive evaluation of liver metabolism by 2H and 13C NMR isotopomer analysis of human urine‏ ‎‡9  1‏
919 ‎‡a  metabolicplasticityforsubcutaneousfataccumulationinalongdistancemigratorybirdtracedby2h2o‏ ‎‡A  Metabolic plasticity for subcutaneous fat accumulation in a long-distance migratory bird traced by 2H2O.‏ ‎‡9  1‏
919 ‎‡a  metabolicincorporationofh218ointospecificglucose6phosphateoxygensbyredbloodcelllysatesasobservedby13100isotopeshiftednmrsignals‏ ‎‡A  Metabolic incorporation of H2 18 O into specific glucose-6-phosphate oxygens by red-blood-cell lysates as observed by 13 C isotope-shifted NMR signals‏ ‎‡9  1‏
919 ‎‡a  metaboliccharacterisationofplasmainjuvenileswithglycogenstoragediseasetype1agsd1abyhighresolution1hnmrspectroscopy‏ ‎‡A  Metabolic characterisation of plasma in juveniles with glycogen storage disease type 1a (GSD1a) by high-resolution1H NMR spectroscopy‏ ‎‡9  1‏
919 ‎‡a  metaboliccharacterisationofplasmainjuvenileswithglycogenstoragediseasetype1a‏ ‎‡A  Metabolic characterisation of plasma in juveniles with glycogen storage disease type 1a‏ ‎‡9  1‏
919 ‎‡a  mechanismsunderlyingthepathogenesisofisolatedimpairedglucosetoleranceinhumans‏ ‎‡A  Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans.‏ ‎‡9  1‏
919 ‎‡a  measurementofgluconeogenesisandpyruvaterecyclingintheratliverasimpleanalysisofglucoseandglutamateisotopomersduringmetabolismofpropionate‏ ‎‡A  Measurement of gluconeogenesis and pyruvate recycling in the rat liver: a simple analysis of glucose and glutamate isotopomers during metabolism of [1,2,3-(13)C3]propionate.‏ ‎‡9  1‏
919 ‎‡a  ketonebodieseffectivelycompetewithglucoseforneuronalacetylcoagenerationinrathippocampalslices‏ ‎‡A  Ketone bodies effectively compete with glucose for neuronal acetyl-CoA generation in rat hippocampal slices‏ ‎‡9  1‏
919 ‎‡a  intestinalmicrobialandmetabolicprofilingofmicefedwithhighglucoseandhighfructosediets‏ ‎‡A  Intestinal Microbial and Metabolic Profiling of Mice Fed with High-Glucose and High-Fructose Diets‏ ‎‡9  1‏
919 ‎‡a  inductionoflipogenesisinwhitefatduringcoldexposureinmicelinktoleanphenotype‏ ‎‡A  Induction of lipogenesis in white fat during cold exposure in mice: link to lean phenotype.‏ ‎‡9  1‏
919 ‎‡a  improvingmetaboliccontrolthroughfunctionalfoods‏ ‎‡A  Improving Metabolic Control Through Functional Foods.‏ ‎‡9  1‏
919 ‎‡a  impairedinsulinstimulationofmuscularatpproductioninpatientswithtype1diabetes‏ ‎‡A  Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes‏ ‎‡9  1‏
919 ‎‡a  impactofdietarystarchonextrahepatictissuelipidmetabolisminfarmedeuropeandicentrarchuslabraxandasianseabasslatescalcarifer‏ ‎‡A  Impact of dietary starch on extrahepatic tissue lipid metabolism in farmed European (Dicentrarchus labrax) and Asian seabass (Lates calcarifer)‏ ‎‡9  1‏
919 ‎‡a  hepaticudpglucose13cisotopomersfromglucoseasimpleanalysisby13cnmrofurinarymentholglucuronide‏ ‎‡A  Hepatic UDP-glucose 13C isotopomers from [U-13C]glucose: a simple analysis by 13C NMR of urinary menthol glucuronide.‏ ‎‡9  1‏
919 ‎‡a  hepaticanapleroticoutflowfluxesareredirectedfromgluconeogenesistolactatesynthesisinpatientswithtype1aglycogenstoragedisease‏ ‎‡A  Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease.‏ ‎‡9  1‏
919 ‎‡a  glycatedhemoglobinandassociatedriskfactorsinolderadults‏ ‎‡A  Glycated hemoglobin and associated risk factors in older adults.‏ ‎‡9  1‏
919 ‎‡a  expressionalregulationofkeyhepaticenzymesofintermediarymetabolismineuropeanseabassdicentrarchuslabraxduringfooddeprivationandrefeeding‏ ‎‡A  Expressional regulation of key hepatic enzymes of intermediary metabolism in European seabass (Dicentrarchus labrax) during food deprivation and refeeding.‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  LC|no2019147111‏
996 ‎‡2  ISNI|0000000391288160‏
996 ‎‡2  DNB|1197162305‏
996 ‎‡2  LC|n 84193148‏
996 ‎‡2  LC|n 88631449‏
996 ‎‡2  J9U|987007371261405171‏
996 ‎‡2  LC|n 84006227‏
996 ‎‡2  NDL|001228212‏
996 ‎‡2  LC|n 92072456‏
996 ‎‡2  DNB|1157386075‏
996 ‎‡2  BIBSYS|7027358‏
996 ‎‡2  LC|n 2014079224‏
996 ‎‡2  CAOONL|ncf11044414‏
996 ‎‡2  SUDOC|196337399‏
996 ‎‡2  BIBSYS|90092753‏
996 ‎‡2  LC|n 86021630‏
996 ‎‡2  LC|nr 93013670‏
996 ‎‡2  ISNI|0000000081211467‏
996 ‎‡2  DNB|121844609‏
996 ‎‡2  CAOONL|ncf10212957‏
996 ‎‡2  LC|nb2002011496‏
996 ‎‡2  ISNI|0000000081531882‏
996 ‎‡2  DNB|1056711663‏
996 ‎‡2  NUKAT|n 2020201214‏
996 ‎‡2  DNB|11461394X‏
996 ‎‡2  SUDOC|147539625‏
996 ‎‡2  LC|n 97002366‏
996 ‎‡2  SUDOC|249121247‏
996 ‎‡2  SUDOC|032653611‏
996 ‎‡2  ISNI|0000000409862272‏
996 ‎‡2  LC|nb2016006996‏
996 ‎‡2  RERO|A025604926‏
996 ‎‡2  LC|n 81029924‏
996 ‎‡2  RERO|A022792272‏
996 ‎‡2  LC|no2017076729‏
996 ‎‡2  NDL|00444875‏
996 ‎‡2  NDL|00444876‏
996 ‎‡2  BLBNB|000443620‏
996 ‎‡2  LC|n 2004074163‏
996 ‎‡2  NYNYRILM|294869‏
996 ‎‡2  RERO|A022879161‏
996 ‎‡2  LC|n 95003676‏
996 ‎‡2  ISNI|0000000035717934‏
996 ‎‡2  N6I|vtls000003361‏
996 ‎‡2  LC|n 87146002‏
996 ‎‡2  BAV|495_261205‏
996 ‎‡2  ISNI|0000000452784345‏
996 ‎‡2  DNB|1195160879‏
996 ‎‡2  ISNI|0000000119332943‏
996 ‎‡2  LC|n 2013028576‏
996 ‎‡2  NTA|069560250‏
996 ‎‡2  SUDOC|182633144‏
996 ‎‡2  LC|no2009171892‏
996 ‎‡2  CAOONL|ncf11757311‏
996 ‎‡2  JPG|500333433‏
996 ‎‡2  DBC|87097991392917‏
996 ‎‡2  LC|no2009062528‏
996 ‎‡2  SUDOC|082613419‏
996 ‎‡2  SUDOC|094674957‏
996 ‎‡2  DNB|172171245‏
996 ‎‡2  PLWABN|9810662694705606‏
996 ‎‡2  W2Z|1542227328341‏
996 ‎‡2  LC|n 94047560‏
996 ‎‡2  ISNI|0000000109945551‏
996 ‎‡2  LC|no2002006786‏
996 ‎‡2  N6I|vtls001383827‏
996 ‎‡2  ISNI|0000000508255865‏
996 ‎‡2  NII|DA08034775‏
996 ‎‡2  SUDOC|265436036‏
996 ‎‡2  JPG|500090171‏
996 ‎‡2  SUDOC|179824554‏
996 ‎‡2  ISNI|0000000054085186‏
996 ‎‡2  DNB|1161678476‏
996 ‎‡2  LC|no2011162852‏
996 ‎‡2  BNF|12338475‏
996 ‎‡2  ISNI|0000000067111099‏
996 ‎‡2  ISNI|0000000033156002‏
996 ‎‡2  LC|n 2013060500‏
996 ‎‡2  ISNI|0000000057318985‏
996 ‎‡2  ISNI|0000000363274829‏
996 ‎‡2  LC|n 2013047301‏
996 ‎‡2  NUKAT|n 01109878‏
996 ‎‡2  SUDOC|265031788‏
996 ‎‡2  ISNI|0000000498290770‏
996 ‎‡2  LC|n 95066834‏
996 ‎‡2  J9U|987007263528005171‏
996 ‎‡2  ISNI|0000000383803978‏
996 ‎‡2  RERO|A024349733‏
996 ‎‡2  ISNI|0000000497795523‏
996 ‎‡2  LC|n 79047096‏
996 ‎‡2  ISNI|0000000039885388‏
996 ‎‡2  DNB|128987332‏
996 ‎‡2  BNF|14609115‏
996 ‎‡2  DNB|140519432‏
996 ‎‡2  LC|no2003121620‏
996 ‎‡2  ISNI|0000000512708230‏
996 ‎‡2  LC|no 92013297‏
996 ‎‡2  DNB|1019485620‏
996 ‎‡2  ISNI|0000000124057771‏
996 ‎‡2  LC|n 2013065825‏
996 ‎‡2  LC|nr 93016618‏
996 ‎‡2  ISNI|0000000496756178‏
996 ‎‡2  ISNI|0000000116132743‏
996 ‎‡2  ISNI|0000000029179260‏
996 ‎‡2  BLBNB|000325698‏
996 ‎‡2  LC|nr 93016610‏
996 ‎‡2  LC|nr 93016612‏
996 ‎‡2  LC|no2013090012‏
996 ‎‡2  LC|nr 93016615‏
996 ‎‡2  ISNI|0000000021832333‏
996 ‎‡2  CAOONL|ncf11300491‏
996 ‎‡2  DNB|1252749570‏
996 ‎‡2  ISNI|0000000073143070‏
996 ‎‡2  ISNI|0000000027353309‏
996 ‎‡2  LC|n 2009181623‏
996 ‎‡2  NTA|072200456‏
996 ‎‡2  NII|DA01761807‏
996 ‎‡2  LC|no 00029817‏
996 ‎‡2  LC|no2003004378‏
996 ‎‡2  LNB|LNC10-000167694‏
996 ‎‡2  ISNI|000000050006129X‏
996 ‎‡2  DNB|115725957X‏
996 ‎‡2  NTA|316026344‏
996 ‎‡2  LC|nb2009014572‏
996 ‎‡2  ISNI|0000000045404931‏
996 ‎‡2  LC|nb2009014577‏
996 ‎‡2  BIBSYS|90778518‏
996 ‎‡2  NTA|292535155‏
996 ‎‡2  BNF|15012125‏
996 ‎‡2  LNB|LNC10-000151260‏
996 ‎‡2  LC|no 99044911‏
996 ‎‡2  LC|nb2007006565‏
996 ‎‡2  LC|no 98068768‏
996 ‎‡2  LC|n 2018036296‏
996 ‎‡2  NTA|072829664‏
996 ‎‡2  ISNI|0000000067864533‏
996 ‎‡2  NII|DA11061062‏
996 ‎‡2  NTA|068287348‏
996 ‎‡2  SUDOC|271063351‏
996 ‎‡2  LC|n 90667914‏
996 ‎‡2  BNE|XX1006703‏
996 ‎‡2  LC|n 85075064‏
996 ‎‡2  LC|no 98103047‏
996 ‎‡2  LC|no2018156537‏
996 ‎‡2  NII|DA18538990‏
996 ‎‡2  BIBSYS|90516513‏
996 ‎‡2  BNF|12488410‏
996 ‎‡2  NII|DA19985597‏
996 ‎‡2  ISNI|0000000457897154‏
996 ‎‡2  NKC|jo20191058822‏
996 ‎‡2  LC|n 2022057226‏
996 ‎‡2  ISNI|000000003482878X‏
996 ‎‡2  ISNI|0000000041679663‏
996 ‎‡2  ISNI|0000000058922447‏
996 ‎‡2  LC|no2007091540‏
996 ‎‡2  LC|no2010070064‏
996 ‎‡2  DNB|1055201157‏
996 ‎‡2  N6I|vtls000286195‏
996 ‎‡2  ISNI|0000000048229796‏
996 ‎‡2  CAOONL|ncf11253236‏
996 ‎‡2  LC|no 95044287‏
996 ‎‡2  ISNI|0000000078075142‏
996 ‎‡2  SUDOC|182358895‏
996 ‎‡2  CAOONL|ncf11328071‏
996 ‎‡2  NDL|032320250‏
996 ‎‡2  BNF|16199867‏
996 ‎‡2  NTA|308204115‏
996 ‎‡2  LC|n 84068379‏
996 ‎‡2  CAOONL|ncf12105983‏
996 ‎‡2  ISNI|0000000075752662‏
996 ‎‡2  N6I|vtls001409135‏
996 ‎‡2  ISNI|0000000045625101‏
996 ‎‡2  LC|no2010023327‏
996 ‎‡2  LC|n 90714551‏
996 ‎‡2  DNB|1061057771‏
996 ‎‡2  SUDOC|028301625‏
996 ‎‡2  NTA|072936460‏
996 ‎‡2  LC|no2016057802‏
996 ‎‡2  CAOONL|ncf10627243‏
996 ‎‡2  LC|no2023113636‏
996 ‎‡2  NLA|000035252543‏
996 ‎‡2  LC|n 2014065657‏
996 ‎‡2  ISNI|0000000058890748‏
996 ‎‡2  ISNI|0000000074173706‏
996 ‎‡2  ISNI|0000000128450626‏
996 ‎‡2  CAOONL|ncf11245236‏
996 ‎‡2  RERO|A024914515‏
996 ‎‡2  BIBSYS|90850759‏
996 ‎‡2  NII|DA11503910‏
996 ‎‡2  LC|n 90647459‏
996 ‎‡2  NKC|ola2015872651‏
996 ‎‡2  LC|no2016152152‏
996 ‎‡2  ISNI|0000000381803405‏
996 ‎‡2  NII|DA01589374‏
996 ‎‡2  ISNI|0000000388513830‏
996 ‎‡2  NUKAT|nx2023781515‏
996 ‎‡2  PLWABN|9812692690005606‏
996 ‎‡2  ISNI|0000000110723884‏
996 ‎‡2  N6I|vtls000106612‏
996 ‎‡2  DNB|1018247335‏
996 ‎‡2  BNF|15058081‏
996 ‎‡2  DBC|87097991138549‏
996 ‎‡2  PLWABN|9810586690705606‏
996 ‎‡2  ISNI|0000000121485471‏
996 ‎‡2  ISNI|0000000048835905‏
996 ‎‡2  BNF|12018868‏
996 ‎‡2  NSK|000495473‏
996 ‎‡2  NUKAT|n 2004086311‏
996 ‎‡2  BIBSYS|97033634‏
996 ‎‡2  LC|no2022026395‏
996 ‎‡2  CAOONL|ncf11333677‏
996 ‎‡2  CAOONL|ncf11417601‏
996 ‎‡2  LC|no2006095895‏
996 ‎‡2  ISNI|0000000370107877‏
996 ‎‡2  DNB|118892703‏
996 ‎‡2  LC|no2011191838‏
996 ‎‡2  ISNI|0000000400226720‏
996 ‎‡2  BNCHL|10000000000000000139262‏
996 ‎‡2  ISNI|0000000062945617‏
996 ‎‡2  NUKAT|n 2003030808‏
996 ‎‡2  LC|n 86100704‏
996 ‎‡2  ISNI|0000000440078830‏
996 ‎‡2  LC|no2009026433‏
996 ‎‡2  BNF|17719424‏
996 ‎‡2  ISNI|0000000398687623‏
996 ‎‡2  LC|no2023104018‏
996 ‎‡2  LC|n 92001031‏
996 ‎‡2  LC|n 85231464‏
996 ‎‡2  LC|no2012125389‏
996 ‎‡2  NUKAT|nx2023729290‏
996 ‎‡2  PLWABN|9810549975505606‏
996 ‎‡2  BIBSYS|6010309‏
996 ‎‡2  ISNI|0000000373354072‏
996 ‎‡2  CAOONL|ncf10409299‏
996 ‎‡2  LNB|LNC10-000217946‏
996 ‎‡2  RERO|A011704522‏
996 ‎‡2  ISNI|0000000107993998‏
996 ‎‡2  ISNI|0000000052265781‏
996 ‎‡2  ISNI|0000000033153338‏
996 ‎‡2  NTA|067811035‏
996 ‎‡2  DNB|119327376‏
996 ‎‡2  DNB|1333575955‏
996 ‎‡2  J9U|987007359338805171‏
996 ‎‡2  NYNYRILM|329‏
996 ‎‡2  BNC|981058514616506706‏
996 ‎‡2  ERRR|11435872‏
996 ‎‡2  LC|n 2001027631‏
996 ‎‡2  LC|n 85258976‏
996 ‎‡2  LC|no2011030074‏
996 ‎‡2  LC|no2022149322‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏